Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice

2012-05-01

Leukemia and Lymphoma , Volume 53 - Issue 5 p. 982- 984

Additional Metadata
Persistent URL	doi.org/10.3109/10428194.2011.643407, hdl.handle.net/1765/52754
Journal	Leukemia and Lymphoma
Organisation	Department of Hematology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Johnsen, H., Haioun, C., Lugtenburg, P., Salar, A., Jaeger, U., Pettengell, R., … Duehrsen, U. (2012). Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice. Leukemia and Lymphoma, 53(5), 982–984. doi:10.3109/10428194.2011.643407

Publication